About Us
CardiaCare is a clinical stage Digital Therapeutic company that develops the world’s first closed loop wearable for non-invasive treatment of cardiac and other Central Nervous System related clinical symptoms.
Providing a non-invasive, nerve stimulation treatment with continuous monitoring and AI based alerts capabilities, CardiaCare’s device is the only platform that enables complete remote patient management and personalized treatment.
The device stems from many years of treatment of real-world patients and integrates know how and innovation from diverse disciplines.
CardiaCare has a functional prototype and successfully completed a FIM study.
CardiaCare is a 2022 MedTech Innovator cohort company.
Our Team
Management
Ofer Halbreich
CEO
Seasoned executive with over 20 years of global leadership experience with focus on business Development, joint ventures, global operations and strategic planning. LLB, MBA (finance).
Amos Ziv
CSO
MSc, Expert in integrative cardiovascular support, Former Head of Integrative Medicine Research Unit, Assaf Harofeh Medical Centre
Tsahi Holand
CTO
MSc, Senior engineer with over 10 years R&D experience in major companies, with focus on signal processing and embedded software applications, board & FPGA design
Cheli Gonnen
Clinical Affairs
MSc, Clinical affairs professional with 15 years of experience in global clinical trials management and monitoring in medical device and pharmaceutical companies.
Advisors
Prof. Vivek Y. Reddy
MD
Advisory Board. Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and the Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at Icahn School of Medicine at Mount Sinai.
Prof. Natasja de Groot
MD, PhD
Advisory Board. Director of the LowLands Bioelectronic Medical Institute and Translational Electrophysiology Laboratory, department of Cardiology, Erasmus University Medical Center and Department of Microelectronics of Delft University of Technology; Founder Atrial Fibrillation Innovation Platform
Prof. Roy Beinart
MD
Advisory Board. Electrophysiologist - Department of Cardiology, Head of the Davidoff Arrhythmia Center - Sheba Medical Center, Secretary of The Israeli Association of Electrophysiology
Ron Sacher
MBA
Advisory Board. MBA (Harvard), CEO of Premia Spine, seasoned medical device executive. Has led several M&A deals with key strategics (sold SI Therapies)
Prof. Daniel Burkhoff
M.D., Ph.D
Director of Heart Failure, Hemodynamics and Mechanical Circulatory Support Research. at Cardiovascular Research Foundation . Seasoned medical device consultant focused on development and research of medical devices